PROJECTION, not a promise: four quarters at the latest declared rate of $0.94. Boards raise, cut and suspend dividends; this table will be wrong whenever they do.
| Approx. period | Per share | Cumulative |
|---|---|---|
| 2026-09 | $0.94 | $0.94 |
| 2026-12 | $0.94 | $1.88 |
| 2027-03 | $0.94 | $2.82 |
| 2027-06 | $0.94 | $3.76 |
Assumes the latest declared quarterly rate holds — a projection, not a promise. Taxes and reinvestment not modeled (see the DRIP calculator for compounding).
| Fiscal quarter ending | Declared per share |
|---|---|
| 2026-06-30 | $0.94 |
| 2026-03-31 | $0.94 |
| 2025-12-31 | $0.88 |
| 2025-09-30 | $0.88 |
| 2025-06-30 | $0.88 |
| 2025-03-31 | $0.88 |
Every historical figure above is what REGENERON PHARMACEUTICALS, INC. itself reported: per-share dividends declared each fiscal quarter; everything beyond that is the current rate carried forward and says so. Yield is trailing, computed against the last end-of-day close — a forward yield differs the moment the rate changes. Educational information, not investment advice.
What is REGN's dividend yield?
Trailing twelve months, REGN declared $3.64 per share; against its last close of $753.12 that is a 0.48% trailing yield. Forward yield differs when the rate changes.
Is REGN's dividend growing?
Not enough filed history yet to compute a year-over-year comparison.
When is REGN's next dividend?
We do not show a declared next payment date: the figures here come from the company’s own filings, which record what was declared each quarter. The projected schedule carries the latest quarterly rate forward and is labeled as a projection.
Keep going: REGN workspace · DRIP calculator · dividend yield, defined · look up another payer